Flash News / Edenred shares drop over...

EDEN

Edenred shares drop over 13% after Q3 revenue miss, narrowed 2024 guidance

investing.com 24/10/2024 - 09:33 AM

Edenred Shares Plummet After Q3 Results

Investing.com — Shares of Edenred (EPA:EDEN) fell sharply on Thursday following the release of its Q3 results, missing revenue expectations by about 2% and providing a more cautious outlook for 2025 and 2026.

At 5:34 am (0934 GMT), Edenred was trading 13.8% lower at €29.65.

Edenred reported total revenues of €682 million, which fell short of the consensus estimate of €695 million. The company also narrowed its 2024 EBITDA guidance to €1,245–1,285 million, shifting to the middle of its previous range of €1,230–1,300 million.

The shortfall in revenue was driven by weaker performance across key divisions and regions. Employee Benefits, one of Edenred's largest segments, reported €398 million in revenue, below consensus estimates of €407 million. Mobility Solutions and Complementary Solutions also lagged behind market expectations, generating revenues of €152 million and €69 million, respectively.

Geographically, the largest miss was in Europe, which generated €367 million compared to the expected €377 million. On a brighter note, Latin America exceeded forecasts with €189 million in revenue, surpassing the consensus of €186 million.

Analysts at Citi Research flagged that the revenue miss, combined with a narrowed guidance, contradicts Edenred’s typical pattern of tightening guidance towards the higher end. This shift may suggest a slowdown in the company's growth momentum, especially in light of potential regulatory changes in key markets.

A major concern raised by Citi is the proposed 5% fee cap on meal vouchers in Italy, expected to take effect in the first half of 2025. Edenred has opposed this proposal; however, if enacted, it could lead to an estimated €60 million decrease in sales for that year. In 2025, Citi anticipates the fee cap to impact EBITDA growth, with a growth rate of over 10% compared to the mid-term target of 12%.

Due to the regulatory uncertainty in Italy and already moderated growth expectations for EBITDA in 2025 and 2026, Edenred's outlook has become less favorable, putting pressure on its stock.




Comments (0)

    Greed and Fear Index

    Note: The data is for reference only.

    index illustration

    Extreme Greed

    84